KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $224.0 million.

  • Bristol Myers Squibb's Receivables - Other fell 4300.25% to $224.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year decrease of 4300.25%. This contributed to the annual value of $1.7 billion for FY2024, which is 31706.73% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Receivables - Other stood at $224.0 million for Q3 2025, which was down 4300.25% from $248.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Receivables - Other's 5-year high stood at $2.2 billion during Q1 2023, with a 5-year trough of $224.0 million in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's median Receivables - Other value was $419.0 million (recorded in 2022), while the average stood at $891.5 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Receivables - Other crashed by 8145.45% in 2024, and later soared by 32598.04% in 2025.
  • Bristol Myers Squibb's Receivables - Other (Quarter) stood at $361.0 million in 2021, then skyrocketed by 39.61% to $504.0 million in 2022, then fell by 17.46% to $416.0 million in 2023, then skyrocketed by 317.07% to $1.7 billion in 2024, then tumbled by 87.09% to $224.0 million in 2025.
  • Its last three reported values are $224.0 million in Q3 2025, $248.0 million for Q2 2025, and $1.7 billion during Q1 2025.